Service de Pneumologie, Oncologie Thoracique et Soins Intensifs Respiratoires
Rouen, Normandy, 76031, France
NCT Number: NCT03018470
Acute exacerbation of COPD (AECOPD) worsen prognosis and quality of life of COPD patients. Telemonitoring could be a useful tool for early identification of AECOPD. Parameters that have to be monitored are not well defined.
Patients with severe COPD may use home non-invasive ventilation (NIV). NIV have built-in software which are recording the breathing pattern of patients when used. The aim of this study is to identify ventilation parameters that are modified at the early stage of an AECOPD.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Rouen, Normandy, 76031, France
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Analysis of breathing pattern using data obtained from NIV built-in software
Time frame: 10 days
Time frame: 10 days
Time frame: 10 days
Time frame: 10 days
Time frame: 10 days
Time frame: 10 days
Time frame: 10 days
Time frame: 10 days
Time frame: 10 days
Time frame: 10 days
Time frame: 10 days
Time frame: 10 days
Time frame: 10 days
University Hospital, Rouen
Other
Usefulness of built-in Non-invasive Ventilator Software to Detect the Change in the Breathing Pattern of COPD Patients Under Home Mechanical Ventilation Before an Admission for Acute Exacerbation of COPD.
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04320342
COPD, COPD Exacerbation
Birmingham, Alabama, United States
View Trial DetailsNCT04481555
Azithromycin, COPD
Aarhus, Denmark
View Trial DetailsNCT05492149
COPD, COPD Exacerbation
Montivilliers, Groupe Hospitalier Du Havre, France
View Trial DetailsNCT07185581
COPD, COPD Exacerbation
Istanbul, Turkey (Türkiye)
View Trial Details